Skip to main content
Erschienen in: Intensive Care Medicine 9/2017

03.07.2017 | Focus Editorial

Focus on acute kidney injury

verfasst von: Miet Schetz, Antoine Schneider

Erschienen in: Intensive Care Medicine | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Excerpt

Acute kidney injury (AKI) is extremely common in critically ill patients. Prevention and supportive therapy with renal replacement therapy (RRT) are the only management options. This editorial comments on papers published in Intensive Care Medicine in 2015 and 2016 focusing on epidemiology, diagnosis, prevention, and extracorporeal treatment of AKI. Their main findings are summarized in Fig. 1.
Literatur
1.
Zurück zum Zitat Druml W, Lenz K, Laggner AN (2015) Our paper 20 years later: from acute renal failure to acute kidney injury—the metamorphosis of a syndrome. Intensive Care Med 41:1941–1949CrossRefPubMed Druml W, Lenz K, Laggner AN (2015) Our paper 20 years later: from acute renal failure to acute kidney injury—the metamorphosis of a syndrome. Intensive Care Med 41:1941–1949CrossRefPubMed
2.
Zurück zum Zitat Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423CrossRefPubMed Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423CrossRefPubMed
3.
Zurück zum Zitat Schetz M, Gunst J, Van den Berghe G (2014) The impact of using estimated GFR versus creatinine clearance on the evaluation of recovery from acute kidney injury in the ICU. Intensive Care Med 40:1709–1717CrossRefPubMed Schetz M, Gunst J, Van den Berghe G (2014) The impact of using estimated GFR versus creatinine clearance on the evaluation of recovery from acute kidney injury in the ICU. Intensive Care Med 40:1709–1717CrossRefPubMed
4.
Zurück zum Zitat Geri G, Guillemet L, Dumas F, Charpentier J, Antona M, Lemiale V, Bougouin W, Lamhaut L, Mira JP, Vinsonneau C, Cariou A (2015) Acute kidney injury after out-of-hospital cardiac arrest: risk factors and prognosis in a large cohort. Intensive Care Med 41:1273–1280CrossRefPubMed Geri G, Guillemet L, Dumas F, Charpentier J, Antona M, Lemiale V, Bougouin W, Lamhaut L, Mira JP, Vinsonneau C, Cariou A (2015) Acute kidney injury after out-of-hospital cardiac arrest: risk factors and prognosis in a large cohort. Intensive Care Med 41:1273–1280CrossRefPubMed
5.
Zurück zum Zitat O’Connor ME, Kirwan CJ, Pearse RM, Prowle JR (2016) Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 42:521–530CrossRefPubMed O’Connor ME, Kirwan CJ, Pearse RM, Prowle JR (2016) Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 42:521–530CrossRefPubMed
6.
Zurück zum Zitat Villeneuve PM, Clark EG, Sikora L, Sood MM, Bagshaw SM (2016) Health-related quality-of-life among survivors of acute kidney injury in the intensive care unit: a systematic review. Intensive Care Med 42:137–146CrossRefPubMed Villeneuve PM, Clark EG, Sikora L, Sood MM, Bagshaw SM (2016) Health-related quality-of-life among survivors of acute kidney injury in the intensive care unit: a systematic review. Intensive Care Med 42:137–146CrossRefPubMed
7.
Zurück zum Zitat KDIGO (2012) Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guidelines AKI: AKI definition. Kidney Int 2:19–36CrossRef KDIGO (2012) Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guidelines AKI: AKI definition. Kidney Int 2:19–36CrossRef
8.
Zurück zum Zitat Kellum JA, Bellomo R, Ronco C (2016) Does this patient have acute kidney injury? An AKI checklist. Intensive Care Med 42:96–99CrossRefPubMed Kellum JA, Bellomo R, Ronco C (2016) Does this patient have acute kidney injury? An AKI checklist. Intensive Care Med 42:96–99CrossRefPubMed
9.
Zurück zum Zitat Legrand M, Jacquemod A, Gayat E, Collet C, Giraudeaux V, Launay JM, Payen D (2015) Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med 41:68–76CrossRefPubMed Legrand M, Jacquemod A, Gayat E, Collet C, Giraudeaux V, Launay JM, Payen D (2015) Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med 41:68–76CrossRefPubMed
10.
Zurück zum Zitat Prowle JR (2015) Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications. Intensive Care Med 41:541–543CrossRefPubMed Prowle JR (2015) Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications. Intensive Care Med 41:541–543CrossRefPubMed
11.
Zurück zum Zitat Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, Humphreys BD, Koyner JL, Liu KD, Mour G, Nolin TD, Bihorac A (2016) Clinical use of the urine biomarker [TIMP-2] × [IGFBP7] for acute kidney injury risk assessment. Am J Kidney Dis 68:19–28CrossRefPubMedPubMedCentral Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, Humphreys BD, Koyner JL, Liu KD, Mour G, Nolin TD, Bihorac A (2016) Clinical use of the urine biomarker [TIMP-2] × [IGFBP7] for acute kidney injury risk assessment. Am J Kidney Dis 68:19–28CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A, CLASSIC Trial Group, Scandinavian Critical Care Trials Group (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42:1695–1705CrossRefPubMed Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A, CLASSIC Trial Group, Scandinavian Critical Care Trials Group (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42:1695–1705CrossRefPubMed
13.
Zurück zum Zitat Park JH, Shim JK, Song JW, Soh S, Kwak YL (2016) Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med 42:1398–1407CrossRefPubMed Park JH, Shim JK, Song JW, Soh S, Kwak YL (2016) Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med 42:1398–1407CrossRefPubMed
14.
Zurück zum Zitat Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M, Chen Z, Collins R, Casadei B (2016) Perioperative rosuvastatin in cardiac surgery. N Engl J Med 374:1744–1753CrossRefPubMed Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M, Chen Z, Collins R, Casadei B (2016) Perioperative rosuvastatin in cardiac surgery. N Engl J Med 374:1744–1753CrossRefPubMed
15.
Zurück zum Zitat Billings FTT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ (2016) High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA 315:877–888CrossRefPubMedPubMedCentral Billings FTT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ (2016) High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA 315:877–888CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Truche AS, Darmon M, Bailly S, Clech C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Zaoui P, Laurent V, Goldgran-Toledano D, Sonneville R, Souweine B, Timsit JF, OUTCOMEREA Study Group (2016) Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery. Intensive Care Med 42:1408–1417CrossRefPubMed Truche AS, Darmon M, Bailly S, Clech C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Zaoui P, Laurent V, Goldgran-Toledano D, Sonneville R, Souweine B, Timsit JF, OUTCOMEREA Study Group (2016) Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery. Intensive Care Med 42:1408–1417CrossRefPubMed
17.
Zurück zum Zitat Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D, Group AS (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122–133CrossRefPubMed Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D, Group AS (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122–133CrossRefPubMed
18.
Zurück zum Zitat Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:2190–2199CrossRef Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:2190–2199CrossRef
19.
Zurück zum Zitat Schetz M, Forni LG, Joannidis M (2016) Does this patient with AKI need RRT? Intensive Care Med 42:1155–1158CrossRefPubMed Schetz M, Forni LG, Joannidis M (2016) Does this patient with AKI need RRT? Intensive Care Med 42:1155–1158CrossRefPubMed
20.
Zurück zum Zitat Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S (2015) Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 41:2098–2110CrossRefPubMed Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S (2015) Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 41:2098–2110CrossRefPubMed
Metadaten
Titel
Focus on acute kidney injury
verfasst von
Miet Schetz
Antoine Schneider
Publikationsdatum
03.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 9/2017
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-017-4874-1

Weitere Artikel der Ausgabe 9/2017

Intensive Care Medicine 9/2017 Zur Ausgabe

What's New in Intensive Care

Next steps in ICU pain research

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.